Invasive aspergillosis/therapeutic aspects: Caspofungin;Aspergilloses invasives/aspects thérapeutiques: Caspofungine

Journal de Mycologie Medicale

Volumn 12, Issue 3 SUPPL., 2002, Pages

  Caillot, D ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Caspofungin; Invasive aspergillosis

Indexed keywords

AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CASPOFUNGIN; ITRACONAZOLE; VORICONAZOLE;

ARTICLE; ASPERGILLOSIS; ASPERGILLUS; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERANCE; HUMAN; IN VITRO STUDY; SIDE EFFECT;

EID: 0036743476     PISSN: 11565233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Keating GM, Jarvis B. Caspofungin. Drugs 2001;61(8):1121-9; discussion 1130-1.
2. Abruzzo GK, Gill CJ, Flattery AM et al. Efficacy of the echinocandin caspofungin against disseminated aspergillosis and candidiasis in cyclophosphamide-induced immunosuppressed mice. Antimicrob Agents Chemother 2000;44:2310-8.
3. Caillot D, Mannone L, Cuisenier B, Couaillier JF. Role of early diagnosis and agressive surgery in the management of invasive pulmonary aspergillosis in neutrogenic patients. Clin Microb Infect Dis 2001;7:54-61.